KINIKSA PHARMACEUTICALS LTD's ticker is and the CUSIP is G5269C951. A total of 4 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576,684 | +269.0% | 33,200 | +199.1% | 0.00% | +100.0% |
| Q2 2023 | $156,288 | +73.7% | 11,100 | +19.4% | 0.00% | – |
| Q2 2022 | $90,000 | +23.3% | 9,300 | +27.4% | 0.00% | – |
| Q1 2022 | $73,000 | -49.7% | 7,300 | -40.7% | 0.00% | – |
| Q4 2021 | $145,000 | -72.9% | 12,300 | -73.9% | 0.00% | -100.0% |
| Q3 2021 | $536,000 | -4.5% | 47,100 | +16.9% | 0.00% | 0.0% |
| Q2 2021 | $561,000 | +424.3% | 40,300 | +594.8% | 0.00% | – |
| Q1 2021 | $107,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 41,500 | $601,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 47,100 | $536,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 30,000 | $342,000 | 0.00% |